Related references
Note: Only part of the references are listed.Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly Clinical article
Nicholas F. Marko et al.
JOURNAL OF NEUROSURGERY (2012)
Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
John A. Jane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes Clinical article
Jason P. Sheehan et al.
JOURNAL OF NEUROSURGERY (2011)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas
Christoph P. Hofstetter et al.
NEUROSURGICAL FOCUS (2010)
Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center
Jackson A. Gondim et al.
NEUROSURGICAL FOCUS (2010)
Endoscopic pituitary surgery: a systematic review and meta-analysis Clinical article
Abtin Tabaee et al.
JOURNAL OF NEUROSURGERY (2009)
Endoscopic Endonasal Transsphenoidal Approach Through the Bilateral Nostrils for Pituitary Adenomas
Shigetoshi Yano et al.
NEUROLOGIA MEDICO-CHIRURGICA (2009)
Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly
Philippe Chanson et al.
CLINICAL ENDOCRINOLOGY (2008)
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
I. M. Holdaway et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma
Marco Losa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mortality in acromegaly: A meta analysis
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Gamma knife stereotactic radiosurgery for acromegaly
Einar Osland Vik-Mo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission
Bruce E. Pollock et al.
JOURNAL OF NEUROSURGERY (2007)
Treatment of acromegaly: is there still a place for radiotherapy?
Raquel S. Jallad et al.
PITUITARY (2007)
Gamma knife radiosurgery for acromegaly -: long-term experience
J Jezková et al.
CLINICAL ENDOCRINOLOGY (2006)
Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly
PJ Jenkins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effectiveness and tolerability of 3-year lanreotide Autogel® treatment in patients with acromegaly
P Caron et al.
CLINICAL ENDOCRINOLOGY (2006)
Transsphenoidal microsurgery for newly diagnosed acromegaly: A personal view after more than 1,000 operations
Dieter K. Luedecke et al.
NEUROENDOCRINOLOGY (2006)
Outcome of gamma knife radiosurgery in 82 patients with acromegaly:: Correlation with initial hypersecretion
F Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution
RS Jallad et al.
CLINICAL ENDOCRINOLOGY (2005)
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'
P Nomikos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®
P Caron et al.
CLINICAL ENDOCRINOLOGY (2004)
Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR
PJ Jenkins et al.
HORMONE RESEARCH (2004)
Transsphenoidal surgery for acromegaly in Wales: Results based on stringent criteria of remission
P De et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study
R Attanasio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly
C Beauregard et al.
CLINICAL ENDOCRINOLOGY (2003)
Primary medical therapy for acromegaly: An open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size
JS Bevan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly
P Caron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Failure of radiotherapy in acromegaly
R Cozzi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity
GA Kaltsas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients
JA Verhelst et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Hormonal and metabolic effects of radiotherapy in acromegaly: Long-term results in 128 patients followed in a single center
G Barrande et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly
NR Biermasz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
